CARDLYTICS INC's ticker is CDLX and the CUSIP is 14161W105. A total of 144 filers reported holding CARDLYTICS INC in Q1 2020. The put-call ratio across all filers is 0.83 and the average weighting 0.8%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $9,531,687 | +721.8% | 577,678 | +214.8% | 0.00% | – |
Q2 2023 | $1,159,846 | +51.3% | 183,520 | -18.7% | 0.00% | – |
Q1 2023 | $766,822 | +77.4% | 225,711 | +201.8% | 0.00% | – |
Q4 2022 | $432,269 | -24.6% | 74,787 | +22.6% | 0.00% | – |
Q3 2022 | $573,000 | -74.1% | 61,000 | +51.7% | 0.00% | – |
Q1 2022 | $2,210,000 | -13.3% | 40,200 | +4.3% | 0.00% | – |
Q4 2021 | $2,548,000 | -69.7% | 38,532 | -61.6% | 0.00% | -100.0% |
Q3 2021 | $8,417,000 | +2.5% | 100,261 | +54.9% | 0.00% | 0.0% |
Q2 2021 | $8,214,000 | +130.0% | 64,708 | +98.7% | 0.00% | – |
Q1 2021 | $3,572,000 | -84.1% | 32,564 | -79.3% | 0.00% | -100.0% |
Q4 2020 | $22,496,000 | +246.5% | 157,554 | +71.3% | 0.00% | +100.0% |
Q3 2020 | $6,492,000 | -5.8% | 91,999 | -6.5% | 0.00% | 0.0% |
Q2 2020 | $6,889,000 | +195.4% | 98,427 | +47.5% | 0.00% | – |
Q1 2020 | $2,332,000 | +62.4% | 66,722 | +192.0% | 0.00% | – |
Q4 2019 | $1,436,000 | +439.8% | 22,847 | +187.6% | 0.00% | – |
Q3 2019 | $266,000 | – | 7,944 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Canaan Partners VIII LLC | 1,133,141 | $29,439,000 | 58.62% |
Polaris Venture Management Co. V, L.L.C. | 2,277,342 | $59,165,000 | 46.48% |
CAS Investment Partners, LLC | 2,162,020 | $56,169,000 | 14.39% |
Cannell Capital | 626,975 | $16,289,000 | 4.62% |
Antipodean Advisors LLC | 142,358 | $3,698,000 | 4.50% |
Shannon River Fund Management LLC | 344,230 | $8,943,000 | 1.42% |
REGENTS OF THE UNIVERSITY OF CALIFORNIA | 19,048 | $495,000 | 1.40% |
Tygh Capital Management, Inc. | 176,237 | $4,579,000 | 0.78% |
Penn Capital Management Company, LLC | 263,499 | $6,846,000 | 0.68% |
EAM Global Investors LLC | 56,866 | $1,477,000 | 0.63% |